Zonisamide and Empagliflozin Interaction
Drug interaction information between Zonisamide and Empagliflozin.
Zonisamide and Empagliflozin have a documented minor interaction in FDA labeling.
FDA drug labeling documents a minor-severity interaction between Zonisamide and Empagliflozin. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.
How They Interact
Zonisamide can cause a buildup of acid in your blood by lowering bicarbonate levels. Taking it with this medicine may increase the risk of this chemical imbalance.
What To Do
Your doctor may need to monitor your blood tests more often. Tell your healthcare provider if you feel very tired or have trouble breathing.
Zonisamide Also Interacts With
- Alogliptin moderate
- Ertugliflozin moderate
- Topiramate moderate
- Carbamazepine minor
- Empagliflozin/Linagliptin minor
Empagliflozin Also Interacts With
- Metformin moderate
- Dolutegravir moderate
- Ranolazine moderate
- Metformin/Empagliflozin moderate
- Cimetidine moderate
Frequently Asked Questions
Can I take Zonisamide and Empagliflozin together?
This is a minor interaction. Your doctor may need to monitor your blood tests more often. Tell your healthcare provider if you feel very tired or have trouble breathing.
How serious is the interaction between Zonisamide and Empagliflozin?
This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.
Why do Zonisamide and Empagliflozin interact?
Zonisamide can cause a buildup of acid in your blood by lowering bicarbonate levels. Taking it with this medicine may increase the risk of this chemical imbalance.
Understanding the Zonisamide and Empagliflozin Interaction
FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Zonisamide belongs to the Anticonvulsant (Sulfonamide) class and Empagliflozin belongs to the SGLT2 Inhibitor class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Zonisamide can cause a buildup of acid in your blood by lowering bicarbonate levels. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.
Context around a specific patient determines real-world impact. Zonisamide has 13 total documented interactions on file in this dataset, and Empagliflozin has 10. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor may need to monitor your blood tests more often. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.
An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Zonisamide or Empagliflozin based on a web page, speak with your prescriber or pharmacist before making any change.
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.
Read our methodology - how this data is sourced, computed, and verified.